Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
To define the role of the human immunodeficiency virus type 1 (HIV-1) envelope proteins in virus infection, a series of peptides were synthesized based on various regions of the HIV-1 transmembrane protein gp41. One of these peptides, DP-178, corresponding to a region predictive of alpha-helical secondary structure (residues 643-678 of the HIV-1LAI isolate), has been identified as a potent antiviral agent. This peptide consistently blocked 100% of virus-mediated cell-cell fusion at < 5 ng/ml (IC90 approximately 1.5 ng/ml) and gave an approximately 10 times reduction in infectious titer of cell-free virus at approximately 80 ng/ml. The inhibitory activity was observed at peptide concentrations approximately 10(4) to 10(5) times lower than those at which cytotoxicity and cytostasis were detected. Peptide-mediated inhibition is HIV-1 specific in that approximately 10(2) to 10(3) times more peptide was required for inhibition of a human immunodeficiency virus type 2 isolate. Further experiments showed that DP-178 exhibited antiviral activity against both prototypic and primary HIV-1 isolates. As shown by PCR analysis of newly synthesized proviral DNA, DP-178 blocks an early step in the virus life cycle prior to reverse transcription. Finally, we discuss possible mechanisms by which DP-178 may exert its inhibitory activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
Spectroscopic Determination of Tryptophan and Tyrosine in Proteins*
Edelhoch, H. (1967) · Biochemistry · doi:10.1021/bi00859a010 · Cited by 3,436
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Human Retroviruses and Aids - 1999
Kuiken, C., & Foley, B. (1999) · doi:10.2172/1186019 · Cited by 952
Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1
Kowalski, M., Potz, J., Basiripour, L., Dorfman, T., Goh, W. C., Terwilliger, E., Dayton, A., Rosen, C., Haseltine, W., & Sodroski, J. (1987) · Science · doi:10.1126/science.3629244 · Cited by 848
Rusche, J. R., Javaherian, K., McDanal, C., Petro, J., Lynn, D. L., Grimaila, R., Langlois, A., Gallo, R. C., Arthur, L. O., & Fischinger, P. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3198 · Cited by 620
Self-citationWild, C., Oas, T., McDanal, C., Bolognesi, D., & Matthews, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10537 · Cited by 485
Self-citationA Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion
Wild, C., Greenwell, T., & Matthews, T. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1051 · Cited by 398
Self-citationA General Model for the Transmembrane Proteins of HIV and Other Retroviruses
GALLAHER, W. R., BALL, J. M., GARRY, R. F., GRIFFIN, M. C., & MONTELARO, R. C. (1989) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1989.5.431 · Cited by 368
Human retroviruses and AIDS 1994
Myers, G., Korber, B., Wain-Hobson, S., Jeang, K.-T., Henderson, L. E., & Pavlakis, G. N. (1995) · doi:10.2172/10116202 · Cited by 273
Identification of the Fusion Peptide of Primate Immunodeficiency Viruses
Bosch, M. L., Earl, P. L., Fargnoli, K., Picciafuoco, S., Giombini, F., Wong-Staal, F., & Franchini, G. (1989) · Science · doi:10.1126/science.2541505 · Cited by 250
Cao, J., Bergeron, L., Helseth, E., Thali, M., Repke, H., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2747-2755.1993 · Cited by 223
Dubay, J. W., Roberts, S. J., Brody, B., & Hunter, E. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4748-4756.1992 · Cited by 189
Gabuzda, D. H., Lever, A., Terwilliger, E., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3306-3315.1992 · Cited by 176
Helseth, E., Olshevsky, U., Gabuzda, D. H., Ardman, B. M., Haseltine, W. A., & Sodroski, J. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.6314-6318.1990 · Cited by 135
Kowalski, M. M., Bergeron, L., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.281-291.1991 · Cited by 132
Dalgleish, A. G., Chanh, T. C., Kennedy, R. C., Kanda, P., Clapham, P. R., & Weiss, R. A. (1988) · Virology · doi:10.1016/0042-6822(88)90674-5 · Cited by 127
Owens, R. J., Burke, C., & Rose, J. K. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.570-574.1994 · Cited by 106
Chen, S. S., Lee, C. N., Lee, W. R., McIntosh, K., & Lee, T. H. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3615-3619.1993 · Cited by 104
Bergeron, L., Sullivan, N., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2389-2397.1992 · Cited by 103
Chen, Y., Ebenbichler, C. F., Vornhagen, R., Schulz, T. F., Steindl, F., Böck, G., Katinger, H. W. D., & Dierich, M. P. (1992) · AIDS · doi:10.1097/00002030-199206000-00002 · Cited by 67
Henderson, L. A., & Qureshi, M. N. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82468-1 · Cited by 61
Nehete, P. N., Arlinghaus, R. B., & Sastry, K. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6841-6846.1993 · Cited by 44
Cited by
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
Bosch, B. J., van der Zee, R., de Haan, C. A. M., & Rottier, P. J. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8801-8811.2003 · Cited by 1,489
Metadata
- Authors
- Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., & Matthews, T. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-10-11
- Volume
- 91
- Issue
- 21
- Pages
- 9770-9774
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2036656105
- Cited by
- 931
- References
- 24
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.